Action Observation, Imagery and Execution for Stroke Rehabilitation

NCT ID: NCT03246139

Last Updated: 2021-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-23

Study Completion Date

2020-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The specific study aims will be:

1. To investigate the short- and long-term treatment effects of action observation, imagery, and execution therapy (AOIE) compared with an action observation therapy (AO) group and a control treatment group as controls on different aspects of outcomes in patients with stroke.
2. To examine the neural mechanisms and changes in cortical neural activity after the interventions in stroke patients.
3. To examine the correlations between AOIE-induced brain activation changes and the clinical efficacy of AOIE.
4. To identify who are the possible good responders to the therapy based on baseline motor function and motor imagery ability of the participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators propose a 3-year randomized controlled trial to (1) investigate the short- and long-term treatment efficacy of AOIE, action observation alone, versus control treatment on clinical outcomes of patients with subacute stroke, (2) examine the neural mechanisms and activation changes after the 3 interventions by using an advanced brain imaging technique, magnetoencephalography (MEG), (3) determine the correlations between neural activation changes and clinical outcomes, and (4) identify who are the good responders to the AOIE therapy. An estimated total of 96 patients with subacute stroke will be recruited in this study. All participants will be randomly assigned to receive 1 of the 3 interventions for 3 weeks (a total of 15 sessions). Clinical outcome measures will be conducted at baseline, immediately after treatment (3 weeks), and at 3 months follow-up. The MEG assessment will be conducted at baseline and immediately after treatment (3 weeks). For the MEG study, The investigators anticipate to enroll 12 to 15 patients in each group to complete neuroimaging evaluation because of the specific eligibility criteria and high costs of MEG. The patients can still participate in the study, receiving rehabilitation therapy and clinical evaluations, even if the participants will not be included in the MEG study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Action observation, imagery & execution

Group Type EXPERIMENTAL

Action observation, imagery & execution

Intervention Type BEHAVIORAL

The participants will be asked to observe movements through a video clip, practice motor imagery, and executing the movements that the participants observed.

Action observation

Group Type ACTIVE_COMPARATOR

Action observation

Intervention Type BEHAVIORAL

The participants will be asked to observe videos and then practice what the participants observed.

Control treatment

Group Type ACTIVE_COMPARATOR

Control treatment

Intervention Type BEHAVIORAL

The participants will receive UE training without watching videos or imagining movements/tasks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Action observation, imagery & execution

The participants will be asked to observe movements through a video clip, practice motor imagery, and executing the movements that the participants observed.

Intervention Type BEHAVIORAL

Action observation

The participants will be asked to observe videos and then practice what the participants observed.

Intervention Type BEHAVIORAL

Control treatment

The participants will receive UE training without watching videos or imagining movements/tasks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed as having a unilateral stroke;
* 1 to 12 months after stroke onset
* from 20 to 80 years of age
* a baseline score of the Fugl-Meyer Assessment (FMA) of 20 to 60
* able to follow the study instructions
* capable of participating in therapy and assessment sessions.

Exclusion Criteria

* patients with global or receptive aphasia,
* severe neglect
* major medical problems, or comorbidities that influenced UE usage or caused severe pain

Additionally, if patients have no metal implants, no head traumas or neurosurgical operations, and can perform MEG motor tasks, the participants can additionally participate in the MEG assessment.
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chang Gung Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Wei Hsieh, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Occupational Therapy and Graduate Institute of Behavioral Sciences, College of Medicine, and Healthy Aging Research Center, Chang Gung University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei medical university hospital

Taipei, , Taiwan

Site Status

Taipei Medical University Shuang Ho Hospital

Taipei, , Taiwan

Site Status

Taoyuan Chang Gung Memorial Hospital

Taoyuan, , Taiwan

Site Status

Lo-Sheng Sanatorium and Hospital, Ministry of Health and Welfare

Taoyuan, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N201705016

Identifier Type: OTHER

Identifier Source: secondary_id

201602056A3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.